Skip to content
2000
Volume 7, Issue 4
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Because of the paucity of large, randomized trials concerning the cardiac care of patients with cancer, treatment and prevention of chemotherapy-induced cardiotoxicity must rely on insights gained from small trials and case reports as well as the application of guidelines developed for the general population. In these clinical vignettes, we present patients referred by their oncologists to a cardiologist for specialized evaluation and management of cardiotoxicity with the goal of emphasizing the importance of identifying risk factors for cardiotoxicity, initiating evidence-based therapy, and establishing a close collaboration between oncologists and cardiologists.

Loading

Article metrics loading...

/content/journals/ccr/10.2174/157340311799960654
2011-11-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/ccr/10.2174/157340311799960654
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test